Elanco is gaining market share through innovation (six blockbusters, two fastest-growing products), omni-channel distribution, and diversification across farm and pet segments, both domestic and international. The company has guided for mid-single-digit revenue growth, high-single-digit bottom-line growth, and low-double-digit EPS growth, and the CEO is excited about the next 12-14 months. Animal health industry is durable with strong secular tailwinds from protein demand and pet spending.